Moreover, multi-omics panels incorporating CTL infiltration, tumor mutation burden, PD-L1 expression, and lncRNA profiles have proven to be practical biomarkers for cancer immunotherapy (Yu et al., 2020b). Here, CD274 is linked to cancer.